Role of type I collagen C telopeptide, bone-specific alkaline phosphatase and osteocalcin in the assessment of bone status in postmenopausal women

Journal of Obstetrics and Gynaecology Research

Volumn 35, Issue 1, 2009, Pages 152-159

  Trento, Laura K ^a   Pietropolli, Adalgisa ^a   Ticconi, Carlo ^a   Gravotta, Enrica ^a   De Martino, Massimo U ^a   Fabbri, Andrea ^a   Piccione, Emilio ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Bone mineral density; Bone specific alkaline phosphatase; Osteocalcin; Postmenopausal osteoporosis; Type I collagen C telopeptide

Indexed keywords

ALKALINE PHOSPHATASE BONE ISOENZYME; CARBOXY TERMINAL TELOPEPTIDE; OSTEOCALCIN;

ADULT; ARTICLE; BODY MASS; BONE DENSITY; BONE TURNOVER; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; ENZYME BLOOD LEVEL; FEMALE; FEMUR; HUMAN; MENOPAUSE; OSTEOPENIA; POSTMENOPAUSE OSTEOPOROSIS; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY; SPINE;

ALKALINE PHOSPHATASE; BONE DENSITY; COLLAGEN TYPE I; FEMALE; HUMANS; MIDDLE AGED; OSTEOCALCIN; OSTEOPOROSIS; OSTEOPOROSIS, POSTMENOPAUSAL; PEPTIDES; POSTMENOPAUSE;

EID: 58849147123     PISSN: 13418076     EISSN: 14470756     Source Type: Journal    
DOI: 10.1111/j.1447-0756.2008.00868.x     Document Type: Article

References (20)

1. Kamel HK, O'Connell MB. Introduction: Postmenopausal osteoporosis as a major public health issue. J Manag Care Pharm 2006 12 (6 Suppl A 2 3.
2. Ray NF, Chan JK, Thamer M, Melton LJ. Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: Report from the National Osteoporosis Foundation. J Bone Miner Res 1997 12 : 24 35.
3. Nohara T, Kamei T, Ohta A. Accelerated decrease in bone mineral density in women aged 52-57 years. Tohoku J Exp Med 2006 210 : 341 347.
4. Blake GM, Fogelman I. Role of dual-energy x-ray absorptiometry in the diagnosis and treatment of osteoporosis. J Clin Densitom 2007 10 : 102 110.
5. Cremers S, Garnero P. Biochemical markers of bone turnover in the clinical development of drugs for osteoporosis and metastatic bone disease. Potential uses and pitfalls. Drugs 2006 66 : 2031 2058.
6. Christgau S, Bitsch-Jensen O, Hanover Bjarnason N et al. Serum crosslaps for monitoring the response in individuals undergoing antiresorptive therapy. Bone 2000 26 : 505 511.
7. Kamel H. Postmenopausal osteoporosis: Etiology, current diagnostic strategies, and non-prescription interventions. J Manag Care Pharm 2006 12 (6 Suppl A 4 6.
8. Leeming DJ, Alexanderson P, Karsdal MA, Qvist P, Schalker S, Tanko LB. An update on biomarkers of bone turnover and their utility in biomedical research and clinical practice. Eur J Clin Pharmacol 2006 62 : 781 792.
9. Angbratt M, Moller M. Questionnaire about calcium intake: Can we trust the answers? Osteoporos Int 1999 9 : 220 225.
10. Garnero P, Hausherr E, Chapuy MC et al. Markers of bone resorption predict hip fracture in elderly women: The EPIDOS prospective study. J Bone Miner Res 1996 11 : 1531 1538.
11. Ross P, Knowlton W. Rapid bone loss is associated with increased levels of biochemical markers. J Bone Miner Res 1998 13 : 297 302.
12. Ravn P, Rix M, Andreassen H, Clemmensen B, Bidstrup M, Gunnes M. High bone turnover is associated with low bone mass and spinal fracture in postmenopausal women. Calcif Tissue Int 1997 60 : 255 260.
13. Lofman O, Magnusson P, Toss G, Larsson L. Common biochemical markers of bone turnover predict future bone loss: A 5-year follow-up study. Clin Chim Acta 2005 356 : 75 76.
14. Papakitsou EF, Margioris AN, Dretakis KE et al. Body mass index (BMI) and parameters of bone formation and resorption in postmenopausal women. Maturitas 2004 47 : 185 193.
15. Bruyere O, Collette J, Delmas P et al. Interest of biochemical markers of bone turnover for long-term prediction of new vertebral fracture in postmenopausal osteoporotic women. Maturitas 2003 44 : 259 265.
16. Reginster JY, Henrotin Y, Christansen C et al. Bone resorption in post-menopausal women with normal and low BMD assessed with biochemical markers specific for telopeptide derived degradation products of collagen type I. Calcif Tissue Int 2001 69 : 130 137.
17. Dominguez Cabrera C, Sosa Henriquez M, Traba ML, Alvarez Villafane E, De la Piedra C. Biochemical markers of bone formation in the study of postmenopausal osteoporosis. Osteoporos Int 1998 8 : 147 151.
18. Briot K, Roux C. Les marqueurs biochimiques du remodelage osseux. Gynecol Obstetr Fertil 2005 33 : 1009 1013.
19. Chaki O, Yoshikata I, Kikuchi R et al. The predictive value of biochemical markers of bone turnover for bone mineral density in postmenopausal Japanese women. J Bone Miner Res 2000 15 : 1537 1544.
20. Shuster S. Osteoporosis, a unitary hypothesis of collagen loss in skin and bone. Med Hypoth 2005 65 : 426 432.